News
23-10-2014
Ivac 2L Femoral – clinical study, March 2013
Six Patients participated in IVac 2L 17 Fr. Femoral access. The preliminary positive results indicate that using IVac 2L in High Risk PCI patients with EF > 25%…
23-10-2014
iVAC 2L 17 Fr. CE approved , February 2014
iVAC 2L Femoral fully percutaneous LVAD has been approved with CE mark for commercial use in European countries. The product will be available end of April 2014…
12-10-2014
iVAC 2L Presentation at Euro PCR 2014
Dr. Van Meighen from Erasmus Medical Center Rotterdam will present for the first time his preliminary experience with iVAC 2L in high risk patients. The presentation will be…